Influenza Challenge and the Challenge of Drug Development

J Infect Dis. 2019 Jan 7;219(2):171-172. doi: 10.1093/infdis/jiy413.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents*
  • Drug Development
  • Endonucleases
  • Humans
  • Influenza, Human*
  • Serine Endopeptidases

Substances

  • Antiviral Agents
  • Endonucleases
  • Serine Endopeptidases
  • sfericase